APA (7th ed.) Citation

Meyer Jonathan M. MD, Chepke Craig MD, Bera Rimal B. MD, Pérez-Rodríguez M. Mercedes MD, P., Lundt Leslie MD, Franey Ericha G. PhD, . . . Yonan Chuck PharmD. (2023). Exploring real-world symptom impact and improvement in well-being domains for tardive dyskinesia in VMAT2 inhibitor-treated patients via clinician survey and chart review. American Association of Psychiatric Pharmacists.

Chicago Style (17th ed.) Citation

Meyer Jonathan M. MD, et al. Exploring Real-world Symptom Impact and Improvement in Well-being Domains for Tardive Dyskinesia in VMAT2 Inhibitor-treated Patients via Clinician Survey and Chart Review. American Association of Psychiatric Pharmacists, 2023.

MLA (9th ed.) Citation

Meyer Jonathan M. MD, et al. Exploring Real-world Symptom Impact and Improvement in Well-being Domains for Tardive Dyskinesia in VMAT2 Inhibitor-treated Patients via Clinician Survey and Chart Review. American Association of Psychiatric Pharmacists, 2023.